Breaking News Instant updates and real-time market news.

STT

State Street

$71.35

1.53 (2.19%)

16:16
10/04/16
10/04
16:16
10/04/16
16:16

State Street submits supplementary resolution plan to Federal Reserve, FDIC

State Street announced that it has filed its response to the deficiencies and shortcoming identified by the Federal Reserve and Federal Deposit Insurance Corporation, or FDIC, in April of this year relating to State Street's 2015 resolution plan. State Street, along with other banking institutions with $50B or more in total assets, annually prepares and files a resolution plan, commonly referred to as a "living will" with the Federal Reserve and the FDIC. In its response filed on October 1, State Street describes the actions it has taken to address the areas raised by the regulators and explains the progress it has made in response to the Federal Reserve and FDIC's guidance for its 2017 resolution plan.

  • 26

    Oct

STT State Street
$71.35

1.53 (2.19%)

03/28/16
KBWI
03/28/16
DOWNGRADE
Target $58
KBWI
Underperform
State Street downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl downgraded State Street to Underperform saying risks outweigh rewards following the recent rally in the shares. State Street is a "show-me" stock until management can execute on stated plans and drive returns higher, Kleinhanzl tells investors in a research note. He has a $58 price target for the shares.
03/28/16
03/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ensco (ESV) downgraded to Negative and Underweight at Susquehanna and Barclays, respectively. Susquehanna sees the group being challenged over the next few years even if crude prices recover. Barclays added that it seems "unimpeded downside" in the shares after pushing out recovery assumptions by another year. 2. BB&T (BBT) downgraded to Underweight at Piper Jaffray by analyst Kevin Barker, who said margin and credit pressure will drive underperformance of the shares. He added that auto lenders will see higher credit losses and a material slowdown in loan growth. 3. Parker-Hannifin (PH) downgraded to Sell at Goldman with analyst Joe ritchie saying shares are pricing in a recovery he does not expect to materialize and valuation is stretched. The analyst sees limited balance sheet capacity and bottom quartile EBITDA/organic growth in 2016/2017. 4. State Street (STT) downgraded to Underperform at Keefe Bruyette by analyst Brian Kleinhanzi, who said State Street is a "show-me" stock until management can execute on stated plans and drive returns higher. 5. ExOne (XONE) downgraded to Underperform at Imperial Capital with analyst Saliq Khan saying the shares at current levels are not factoring in the "depressed" energy sector, currency devaluation and the potential for delayed capital equipment purchases. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/16
JEFF
09/06/16
NO CHANGE
Target $80
JEFF
Buy
State Street price target raised to $80 from $74 at Jefferies
Jefferies analyst Ken Usdin raised his price target for State Street to $80 saying the company remains well positioned to beat expectations. Beacon cost initiative progress and "record" Q2 asset servicing wins are not fully appreciated in the shares, Usdin tells investors in a research note. He keeps a Buy rating on State Street in a research note partially titled, "Call it a Comeback."
09/06/16
SDLR
09/06/16
DOWNGRADE
Target $73
SDLR
Hold
State Street downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Jeffery Harte downgraded State Street to Hold citing relative valuation and raised its price target to $73.

TODAY'S FREE FLY STORIES

CORI

Corium

$10.88

0.03 (0.28%)

07:10
09/26/17
09/26
07:10
09/26/17
07:10
Initiation
Corium initiated  »

Corium initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FDS

FactSet

$170.81

2.2 (1.30%)

07:10
09/26/17
09/26
07:10
09/26/17
07:10
Earnings
FactSet reports Q4 adj. EPS $1.90, consensus $1.89 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

LNG

Cheniere Energy

$44.12

0.64 (1.47%)

07:09
09/26/17
09/26
07:09
09/26/17
07:09
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$4.37

0.15 (3.55%)

07:09
09/26/17
09/26
07:09
09/26/17
07:09
Hot Stocks
Chesapeake sees Q3 production 542,000 boe per day »

Chesapeake Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

KTOS

Kratos Defense

$12.72

-0.28 (-2.15%)

07:08
09/26/17
09/26
07:08
09/26/17
07:08
Hot Stocks
Kratos Defense receives $9.7M in contract awards »

Kratos Defense announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVGN

Evogene

$4.54

0.23 (5.34%)

07:08
09/26/17
09/26
07:08
09/26/17
07:08
Hot Stocks
Evogene reports 'positive' results in 2nd year field trials in banana »

Evogene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Axovant Phase 3 Alzheimer's study misses co-primary endpoints »

Axovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AST

Asterias

$3.25

0.05 (1.56%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Asterias receives regulatory clearance to start AST-VAC2 clinical trial »

Asterias Biotherapeutics,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MDXG

MiMedx

$12.35

-0.28 (-2.22%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
MiMedx announces confidential lawsuit settlement with terminated employee »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 13

    Nov

  • 14

    Nov

DRI

Darden

$83.14

0.26 (0.31%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Darden reports Q1 Olive Garden same-restaurant sales up 1.9% »

Reports Q1 same…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AGN

Allergan

$211.61

6.96 (3.40%)

07:05
09/26/17
09/26
07:05
09/26/17
07:05
Recommendations
Allergan analyst commentary  »

Allergan weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZRE

Azure Power

$16.18

0.18 (1.13%)

07:05
09/26/17
09/26
07:05
09/26/17
07:05
Hot Stocks
Azure Power awarded 260 MW solar project in Gujarat »

Azure Power announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEES

H&E Equipment

$26.97

-0.2 (-0.74%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Initiation
H&E Equipment initiated  »

H&E Equipment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$0.94

0.093 (10.98%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Hot Stocks
Northern Oil and Gas announces settlement with former CEO »

Northern Oil and Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Breaking Hot Stocks news story on Darden »

Darden reports Q1 Olive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BTX

BioTime

$2.72

-0.08 (-2.86%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
BioTime announces 'positive' secondary, long-term data from Renevia trial »

BioTime announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MBRX

Moleculin Biotech

$2.41

-0.07 (-2.82%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Moleculin Biotech announces FDA approval of Annamycin IND »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNCA

Genocea

$5.33

0.04 (0.76%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Downgrade
Genocea rating change  »

Genocea downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Darden reports Q1 blended same-restaurant sales from legacy brands up 1.7% »

Q1 same-restaurant sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Earnings
Darden backs FY18 adjusted cont ops EPS view $4.38-$4.50, consensus $4.47 »

The company reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:01
09/26/17
09/26
07:01
09/26/17
07:01
Hot Stocks
Akebia saya Phase 2 vadadustat study confirmed findings from previous studies »

Akebia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

07:00
09/26/17
09/26
07:00
09/26/17
07:00
General news
FX Update: The dollar has been in rally mode »

FX Update: The dollar has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.